Global Hereditary Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201090560 | Category: Service & Software | Pages: 111 | Format: PDF | Published Date: July 14,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Hereditary Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Hereditary Testing market size is estimated to be worth US$ 6531.3 million in 2021 and is forecast to a readjusted size of USD 8801.8 million by 2028 with a CAGR of 4.4% during review period. Hospital accounting for % of the Hereditary Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Hereditary Cancer Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Hereditary Testing include Myriad Genetics, Inc., Invitae Corporation, Illumina, Inc., Natera, Inc., and Laboratory Corporation of America Holdings, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Hereditary Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hereditary Cancer Testing
Hereditary Non-cancer Testing
Market segment by Application, can be divided into
Hospital
Clinic
Laboratory
Others
Market segment by players, this report covers
Myriad Genetics, Inc.
Invitae Corporation
Illumina, Inc.
Natera, Inc.
Laboratory Corporation of America Holdings
F. Hoffmann-La Roche Ltd
Quest Diagnostics Incorporated
CooperSurgical, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Twist Bioscience
Sophia Genetics
Fulgent Genetic, Inc.
Medgenome
CENTOGENE
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hereditary Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hereditary Testing, with revenue, gross margin and global market share of Hereditary Testing from 2019 to 2022.
Chapter 3, the Hereditary Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Hereditary Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Hereditary Testing research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Hereditary Testing
    1.2 Classification of Hereditary Testing by Type
        1.2.1 Overview: Global Hereditary Testing Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Hereditary Testing Revenue Market Share by Type in 2021
        1.2.3 Hereditary Cancer Testing
        1.2.4 Hereditary Non-cancer Testing
    1.3 Global Hereditary Testing Market by Application
        1.3.1 Overview: Global Hereditary Testing Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Laboratory
        1.3.5 Others
    1.4 Global Hereditary Testing Market Size & Forecast
    1.5 Global Hereditary Testing Market Size and Forecast by Region
        1.5.1 Global Hereditary Testing Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Hereditary Testing Market Size by Region, (2017-2022)
        1.5.3 North America Hereditary Testing Market Size and Prospect (2017-2028)
        1.5.4 Europe Hereditary Testing Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Hereditary Testing Market Size and Prospect (2017-2028)
        1.5.6 South America Hereditary Testing Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Hereditary Testing Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Hereditary Testing Market Drivers
        1.6.2 Hereditary Testing Market Restraints
        1.6.3 Hereditary Testing Trends Analysis
2 Company Profiles
    2.1 Myriad Genetics, Inc.
        2.1.1 Myriad Genetics, Inc. Details
        2.1.2 Myriad Genetics, Inc. Major Business
        2.1.3 Myriad Genetics, Inc. Hereditary Testing Product and Solutions
        2.1.4 Myriad Genetics, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Myriad Genetics, Inc. Recent Developments and Future Plans
    2.2 Invitae Corporation
        2.2.1 Invitae Corporation Details
        2.2.2 Invitae Corporation Major Business
        2.2.3 Invitae Corporation Hereditary Testing Product and Solutions
        2.2.4 Invitae Corporation Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Invitae Corporation Recent Developments and Future Plans
    2.3 Illumina, Inc.
        2.3.1 Illumina, Inc. Details
        2.3.2 Illumina, Inc. Major Business
        2.3.3 Illumina, Inc. Hereditary Testing Product and Solutions
        2.3.4 Illumina, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Illumina, Inc. Recent Developments and Future Plans
    2.4 Natera, Inc.
        2.4.1 Natera, Inc. Details
        2.4.2 Natera, Inc. Major Business
        2.4.3 Natera, Inc. Hereditary Testing Product and Solutions
        2.4.4 Natera, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Natera, Inc. Recent Developments and Future Plans
    2.5 Laboratory Corporation of America Holdings
        2.5.1 Laboratory Corporation of America Holdings Details
        2.5.2 Laboratory Corporation of America Holdings Major Business
        2.5.3 Laboratory Corporation of America Holdings Hereditary Testing Product and Solutions
        2.5.4 Laboratory Corporation of America Holdings Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
    2.6 F. Hoffmann-La Roche Ltd
        2.6.1 F. Hoffmann-La Roche Ltd Details
        2.6.2 F. Hoffmann-La Roche Ltd Major Business
        2.6.3 F. Hoffmann-La Roche Ltd Hereditary Testing Product and Solutions
        2.6.4 F. Hoffmann-La Roche Ltd Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
    2.7 Quest Diagnostics Incorporated
        2.7.1 Quest Diagnostics Incorporated Details
        2.7.2 Quest Diagnostics Incorporated Major Business
        2.7.3 Quest Diagnostics Incorporated Hereditary Testing Product and Solutions
        2.7.4 Quest Diagnostics Incorporated Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Quest Diagnostics Incorporated Recent Developments and Future Plans
    2.8 CooperSurgical, Inc.
        2.8.1 CooperSurgical, Inc. Details
        2.8.2 CooperSurgical, Inc. Major Business
        2.8.3 CooperSurgical, Inc. Hereditary Testing Product and Solutions
        2.8.4 CooperSurgical, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 CooperSurgical, Inc. Recent Developments and Future Plans
    2.9 Agilent Technologies, Inc.
        2.9.1 Agilent Technologies, Inc. Details
        2.9.2 Agilent Technologies, Inc. Major Business
        2.9.3 Agilent Technologies, Inc. Hereditary Testing Product and Solutions
        2.9.4 Agilent Technologies, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Agilent Technologies, Inc. Recent Developments and Future Plans
    2.10 Thermo Fisher Scientific, Inc. 
        2.10.1 Thermo Fisher Scientific, Inc. Details
        2.10.2 Thermo Fisher Scientific, Inc. Major Business
        2.10.3 Thermo Fisher Scientific, Inc. Hereditary Testing Product and Solutions
        2.10.4 Thermo Fisher Scientific, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
    2.11 Twist Bioscience
        2.11.1 Twist Bioscience Details
        2.11.2 Twist Bioscience Major Business
        2.11.3 Twist Bioscience Hereditary Testing Product and Solutions
        2.11.4 Twist Bioscience Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Twist Bioscience Recent Developments and Future Plans
    2.12 Sophia Genetics
        2.12.1 Sophia Genetics Details
        2.12.2 Sophia Genetics Major Business
        2.12.3 Sophia Genetics Hereditary Testing Product and Solutions
        2.12.4 Sophia Genetics Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Sophia Genetics Recent Developments and Future Plans
    2.13 Fulgent Genetic, Inc.
        2.13.1 Fulgent Genetic, Inc. Details
        2.13.2 Fulgent Genetic, Inc. Major Business
        2.13.3 Fulgent Genetic, Inc. Hereditary Testing Product and Solutions
        2.13.4 Fulgent Genetic, Inc. Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Fulgent Genetic, Inc. Recent Developments and Future Plans
    2.14 Medgenome
        2.14.1 Medgenome Details
        2.14.2 Medgenome Major Business
        2.14.3 Medgenome Hereditary Testing Product and Solutions
        2.14.4 Medgenome Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Medgenome Recent Developments and Future Plans
    2.15 CENTOGENE
        2.15.1 CENTOGENE Details
        2.15.2 CENTOGENE Major Business
        2.15.3 CENTOGENE Hereditary Testing Product and Solutions
        2.15.4 CENTOGENE Hereditary Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 CENTOGENE Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Hereditary Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Hereditary Testing Players Market Share in 2021
        3.2.2 Top 10 Hereditary Testing Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Hereditary Testing Players Head Office, Products and Services Provided
    3.4 Hereditary Testing Mergers & Acquisitions
    3.5 Hereditary Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Hereditary Testing Revenue and Market Share by Type (2017-2022)
    4.2 Global Hereditary Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Hereditary Testing Revenue Market Share by Application (2017-2022)
    5.2 Global Hereditary Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Hereditary Testing Revenue by Type (2017-2028)
    6.2 North America Hereditary Testing Revenue by Application (2017-2028)
    6.3 North America Hereditary Testing Market Size by Country
        6.3.1 North America Hereditary Testing Revenue by Country (2017-2028)
        6.3.2 United States Hereditary Testing Market Size and Forecast (2017-2028)
        6.3.3 Canada Hereditary Testing Market Size and Forecast (2017-2028)
        6.3.4 Mexico Hereditary Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Hereditary Testing Revenue by Type (2017-2028)
    7.2 Europe Hereditary Testing Revenue by Application (2017-2028)
    7.3 Europe Hereditary Testing Market Size by Country
        7.3.1 Europe Hereditary Testing Revenue by Country (2017-2028)
        7.3.2 Germany Hereditary Testing Market Size and Forecast (2017-2028)
        7.3.3 France Hereditary Testing Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Hereditary Testing Market Size and Forecast (2017-2028)
        7.3.5 Russia Hereditary Testing Market Size and Forecast (2017-2028)
        7.3.6 Italy Hereditary Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Hereditary Testing Revenue by Type (2017-2028)
    8.2 Asia-Pacific Hereditary Testing Revenue by Application (2017-2028)
    8.3 Asia-Pacific Hereditary Testing Market Size by Region
        8.3.1 Asia-Pacific Hereditary Testing Revenue by Region (2017-2028)
        8.3.2 China Hereditary Testing Market Size and Forecast (2017-2028)
        8.3.3 Japan Hereditary Testing Market Size and Forecast (2017-2028)
        8.3.4 South Korea Hereditary Testing Market Size and Forecast (2017-2028)
        8.3.5 India Hereditary Testing Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Hereditary Testing Market Size and Forecast (2017-2028)
        8.3.7 Australia Hereditary Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Hereditary Testing Revenue by Type (2017-2028)
    9.2 South America Hereditary Testing Revenue by Application (2017-2028)
    9.3 South America Hereditary Testing Market Size by Country
        9.3.1 South America Hereditary Testing Revenue by Country (2017-2028)
        9.3.2 Brazil Hereditary Testing Market Size and Forecast (2017-2028)
        9.3.3 Argentina Hereditary Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Hereditary Testing Revenue by Type (2017-2028)
    10.2 Middle East & Africa Hereditary Testing Revenue by Application (2017-2028)
    10.3 Middle East & Africa Hereditary Testing Market Size by Country
        10.3.1 Middle East & Africa Hereditary Testing Revenue by Country (2017-2028)
        10.3.2 Turkey Hereditary Testing Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Hereditary Testing Market Size and Forecast (2017-2028)
        10.3.4 UAE Hereditary Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Hereditary Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?